Improved isoprenoid production
Details for Australian Patent Application No. 2002316966 (hide)
International Classifications
Event Publications
9 January 2003 Complete Application Filed
Priority application(s): 60/296,299 06.06.01 US
8 May 2003 Application Open to Public Inspection
Published as AU-B-2002316966
11 March 2004 Assignment before Grant
Roche Vitamins AG The application has been assigned to DSM IP Assets B.V.
17 May 2007 Application Accepted
Published as AU-B-2002316966
20 September 2007 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 05 Jun 2007. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2003
27 September 2007 Standard Patent Sealed
8 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002316967-VORRICHTUNG UND VERFAHREN ZUR ELEKTRISCHEN BEHANDLUNG SUSPENDIERTER BIOLOGISCHER PARTIKEL
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser